Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01188746 · ClinicalTrials.gov registry record · NA

Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT01188746: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01188746 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01188746, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is look at how treatments for ascites affect quality of life. Your quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced as-ī-tees) is the presence of extra fluid in the abdomen. Sometimes ascites is caused by cancer, also called malignancy. All people who participate in this study have ascites associated with cancer. Ascites can cause symptoms that make it difficult for the patient to do simple things. Patients with ascites often report: Abdominal swelling Difficulty walking. Difficulty breathing. Feeling full when eating. Clothes not fitting due to a swollen abdomen. Swelling in the legs. It is hoped that this catheter will relieve the symptoms of the ascites. The goal of the investigators study is to understand the quality of life before the procedure and after the procedure. Since the patient is having this procedure to make their symptoms better, the investigators want to hear from the patient of how the procedure has affected their quality of life.

Interventions

  • BEHAVIORAL McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2010-08
Est. Completion 2020-02
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01188746

The ClinicalTrials.gov registry entry for NCT01188746 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire is the first listed.

NCT01188746 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01188746 about?

NCT01188746 is a clinical study titled "Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites". The purpose of this study is look at how treatments for ascites affect quality of life. Your quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced as-ī-tees) is the presence of extra fluid in the abdomen. Sometimes ascites is caused by cancer, also called mali...

What is the current status of trial NCT01188746?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-08. Estimated completion is 2020-02.

What interventions are being tested in trial NCT01188746?

The interventions under investigation include: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT01188746?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.